CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.60
+0.21 (2.77%)
Oct 15, 2026, 12:21 PM EDT - Market open
CorMedix Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 592 | 916 | 491 | 206 | 174 | 173 | |
Market Cap Growth | -25.05% | 86.44% | 138.57% | 18.32% | 0.53% | -27.41% |
Enterprise Value | 483 | 1,010 | 446 | 120 | 116 | 102 |
Last Close Price | 7.39 | 11.63 | 8.10 | 3.76 | 4.22 | 4.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.65 | 5.65 | - | - | - | - |
Forward PE | - | 4.15 | 12.27 | - | - | - |
PS Ratio | 1.28 | 2.94 | 11.31 | - | 2662.04 | 907.08 |
PB Ratio | 1.25 | 2.26 | 5.81 | 2.94 | 3.16 | 2.76 |
P/TBV Ratio | 8.19 | - | 5.94 | 2.94 | 3.16 | 2.76 |
P/FCF Ratio | 2.37 | 5.30 | - | - | - | - |
P/OCF Ratio | 2.33 | 5.24 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.05 | 3.24 | 10.26 | - | 1772.75 | 535.14 |
EV/EBITDA Ratio | 1.84 | 5.77 | - | - | - | - |
EV/EBIT Ratio | 2.13 | 6.30 | - | - | - | - |
EV/FCF Ratio | 1.93 | 5.84 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.32 | 0.37 | 0.01 | 0.01 | 0.02 | 0.02 |
Debt / EBITDA Ratio | 0.56 | 0.85 | - | - | - | - |
Debt / FCF Ratio | 0.59 | 0.86 | - | - | - | - |
Net Debt / Equity Ratio | -0.24 | -0.02 | -0.60 | -1.07 | -1.05 | -1.03 |
Net Debt / EBITDA Ratio | -0.42 | -0.06 | 2.32 | 1.54 | 1.90 | 2.20 |
Net Debt / FCF Ratio | -0.44 | -0.06 | 1.01 | 1.95 | 2.36 | 2.86 |
Asset Turnover | 0.80 | 0.66 | 0.43 | - | 0.00 | 0.00 |
Inventory Turnover | 1.88 | 1.18 | 0.63 | - | - | 2.03 |
Quick Ratio | 2.23 | 1.84 | 3.05 | 6.67 | 9.32 | 12.26 |
Current Ratio | 2.56 | 2.11 | 3.39 | 6.97 | 9.44 | 12.44 |
Return on Equity (ROE) | 54.93% | 66.56% | -23.16% | -74.02% | -50.40% | -52.72% |
Return on Assets (ROA) | 24.56% | 21.21% | -13.91% | -42.47% | -29.23% | -31.12% |
Return on Capital Employed (ROCE) | 31.70% | 24.60% | -26.30% | -69.30% | -55.00% | -46.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 31.40% | 17.79% | -3.65% | -22.49% | -17.06% | -16.29% |
FCF Yield | 42.27% | 18.86% | -10.32% | -18.80% | -14.12% | -13.04% |
Buyback Yield / Dilution | -40.04% | -36.41% | -15.65% | -26.39% | -6.93% | -31.87% |